BIO-key International (NASDAQ:BKYI) Issues Q4 2023 Earnings Guidance

BIO-key International (NASDAQ:BKYIGet Free Report) updated its fourth quarter 2023 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of -5.540–5.540 for the period. The company issued revenue guidance of -. BIO-key International also updated its FY 2023 guidance to -11.450–11.450 EPS.

BIO-key International Stock Down 7.4 %

Shares of NASDAQ:BKYI opened at $2.00 on Wednesday. The company has a market cap of $1.52 million, a price-to-earnings ratio of -0.12 and a beta of 0.41. BIO-key International has a 12 month low of $1.74 and a 12 month high of $15.30. The company has a current ratio of 1.30, a quick ratio of 0.59 and a debt-to-equity ratio of 0.07. The company has a 50-day moving average price of $1.98 and a 200 day moving average price of $3.59.

About BIO-key International

(Get Free Report)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Featured Articles

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.